Searched for
DIALYSIS SERVICES MARKET
L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...- Public-private projects key to expand access to Kidney care: NephroPlusNephroPlus, India's leading provider of dialysis services, is on a mission to reshape the future of kidney health with an innovative tech-b...
- Lord's Mark Industries Ltd. announces AI-supported Dialysis ecosystem launchLord's Mark Industries Ltd. has launched an integrated dialysis ecosystem in Ahmedabad, featuring the AI-driven Renalyx Machine. This CE-ce...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- Nephrocare Health shares list at 7% premium over IPO priceNephrocare Health Services debuted on stock exchanges with a 7% premium, opening at Rs 491.70 on BSE and Rs 490 on NSE. The company's Rs 87...
- Nephrocare Health IPO Day 3: GMP slips to 2% and subscription remains subdued — Should you apply?Nephrocare Health IPO: The stock’s grey-market premium has slipped to 1.7% from 4.35%, indicating softer sentiment and a likely listing ran...
- Nephrocare Health IPO Day 2: GMP improves but subscription demand remains weak. Should you apply?Nephrocare Health Services’ Rs 871-crore IPO has seen a muted initial response despite an improving grey market premium. Strong financial g...
- Can Nephrocare’s IPO prove a rewarding bet for long-term investors?Nephrocare Health Services, a leading dialysis provider, is set to raise funds through an IPO. The company aims to repay debt and invest in...
- NephroPlus' Rs 871-cr IPO to open on Dec 10; sets price band at Rs 438-460/shareDialysis services provider Nephrocare Health Services Ltd, known for its brand NephroPlus, on Thursday announced a price band of Rs 438-460...
- NephroPlus announces IPO launch on December 10. Check key detailsNephrocare Health Services’ IPO opens December 10 with a fresh issue and OFS totaling significant funds. Proceeds will support new dialysis...
- NephroPlus set to launch IPO open on Dec 10; eyes Rs 353-cr via fresh issueDialysis services provider Nephrocare Health Services Ltd, known for its brand NephroPlus, is set to launch its initial public offering, co...
- NephroPlus gets Sebi nod to launch IPO, to raise Rs 353 crore from fresh issueDialysis services leader Nephrocare Health Services, operating under NephroPlus, has received Sebi’s approval to launch its IPO, comprising...
- IPO-bound NephroPlus scales operations to 500 clinics, across India, Nepal, Philippines, UzbekistanIPO-bound NephroCare Health Services on Wednesday said it has scaled its operations from one clinic in India in 2010 to 500 clinics, across...
- Dialysis chain NephroPlus eyes Rs 2,000 crore IPONephrocare Health Services, known as NephroPlus, is set to file its DRHP with SEBI by the end of this month, aiming to raise over ₹2,000 cr...
- Quadria Capital picks up stake in NephroPlus for $102 mlnQuadria Capital invests $102 million in NephroPlus, India's largest dialysis chain, acquiring a minority stake. The move supports NephroPlu...
- Dialysis chain NephroPlus raises Rs 182 crore in Series E roundThe fresh capital will be used by the Hyderabad-based company to pursue growth opportunities across India and select International markets.
- Tata Capital sells stake in Indian dialysis service provider to Fresenius Medical CareFMC’s acquisition of Sandor marks the beginning of a series of investments the company intends for its expansion in the Indian dialysis mar...
- Fresenius acquires 85 per cent stake in Sandor Nephro ServicesEstablished in 2011, Sandor Nephro Services operates around 55 dialysis centres while Fresenius Medical Care runs three such centres across...
- Health startups offer low-cost treatment and link patients with local doctorsRecent changes in the Drug Price Control Act, which reduced the operational margins for pharmacies and other retailers from 20% to about 14...
- US-based DaVita picks up stake in NephroLife Care for India entryUS-based kidney care services provider DaVita has picked up a significant stake in Bangalore-based renal care services provider NephroLife ...
Load More
